# Baxalta US Inc. – FDA Inspection, Sep 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/95291689-7d92-4668-a518-7c2443655647
Source feed: FDA_Inspections

> FDA inspection 1279237 of Baxalta US Inc., September 18, 2025. 2 citations under 21 CFR parts 211 and 803. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279237
- Company Name: Baxalta US Inc.
- Inspection Date: 2025-09-18
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1166545 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/0a393ccc-bf48-4160-8b4c-45d96b6b62fb)
- [FDA Inspection 1118072 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/1e6d6d48-82cf-4812-9ae5-37c4ede74bed)
- [FDA Inspection 1038757 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/67db9420-6ce8-4bd7-a8b9-1dfa5e54a11d)
- FDA Inspection 972505 - 2016-03-10
- FDA Inspection 870344 - 2014-02-28

## Related Officers

- [Alan L. Truong](https://www.keypedia.com/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)
- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)

Company: https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
